Skip to main content
SpringerLink
Log in

New and Future Therapies for Osteoarthritis

  • Chapter
Osteoarthritis

Abstract

Over the last decade, there have been several interesting advances in the treatment of osteoarthritis (OA), resulting in renewed interest in this field of medicine. Recent progress in the understanding of the pathophysiology of OA has facilitated the development of new drugs and treatments specifically aimed at effectively retarding the disease process. This chapter presents several new agents that have been introduced for the symptomatic treatment of OA. These medications have different mechanisms of action, some of which are not yet fully understood. Clinical studies are currently underway for some of those drugs to determine if they can exert structure-modifying effects to counteract the disease process. This chapter also reviews major fields of investigation that we believe hold promise for the near future.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cruz TF, Tang J, Pronost S, Pujol JP (1996) Molecular mechanisms implicated in the inhibition of collagenase expression by diacerhein. Rev Prat 46: S15–S19

    PubMed  CAS  Google Scholar 

  2. Carney SL, Hicks CA, Tree B, Broadmore RJ (1995) An in vivo investigation of the effect of anthraquinones on the turnover of aggrecans in spontaneous osteoarthritis in the guinea pig. Inflamm Res 44: 182–186

    PubMed  CAS  Google Scholar 

  3. Bendele AM, Bendele RA, Hulman JF, Swann BP (1996) Beneficial effects of treatment with diacerhein in guinea pigs with osteoarthritis. Rev Prat Ed Fr 46: S35–S39

    CAS  Google Scholar 

  4. Nguyen M, Dougados M, Berdah L, Amor B (1994) Diacerhein in the treatment of osteoarthritis of the hip. Arthritis Rheum 37: 529–536

    PubMed  CAS  Google Scholar 

  5. Marcolongo R, Fioravanti A, Adami S, Tozzi E, Mian M, Zampieri A (1988) Efficacy and tolerability of diacerhein in the treatment of osteoarthritis. Curr Therap Res 43: 878–887

    Google Scholar 

  6. Mauviel A, Daireaux M, Hartmann DJ, Galera P, Loyau G, Pujol JP (1989) Effects of unsaponifiable extracts of avocado/soy beans (PIAS) on the production of collagen by cultures of synoviocytes, articular chondrocytes and skin fibroblasts. Rev Rhum Mai Osteoartic 56: 207–211

    CAS  Google Scholar 

  7. Henrotin Y, Labasse A, Jaspar JM, De Groote D, Zheng SX, Guillou B, Reginster JY (1998) Effects of three avocado/soybean unsaponifiable mixtures on metalloproteinases, cytokines and prostaglandin E2 production by human articular chondrocytes. Clin Rheumatol (In Press)

    Google Scholar 

  8. Maheu E, Mazieres B, Valat JP, Loyau G, Le Loet X, Bourgeois P, Grouin JM, Rozenberg S (1998) Symptomatic efficacy of avocado/soybean unsaponifiables in the treatment of osteoarthritis of the knee and hip: a prospective, randomized, double-blind, placebocontrolled, multicenter clinical trial with a six-month treatment period and a two- month follow-up demonstrating a persistent effect. Arthritis Rheum 41: 81–91

    PubMed  CAS  Google Scholar 

  9. Blotman F, Maheu E, Wulwik A, Caspar H, Lopez A (1998) Efficacite et tolerance des insaponifiables d’avocat/soja dans le traitement de la gonarthrose et de la coxarthrose symptomatique. Rev Rhum (In Press)

    Google Scholar 

  10. Bassleer C, Henrotin Y, Franchimont P (1992) In vitro evaluation of drugs proposed as chondroprotective agents. Int J Tissue React 14: 231–241

    PubMed  CAS  Google Scholar 

  11. Müller-Fasbender H, Bach G, Haase W, Rovati LC, Setnikar I (1994) Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee. Osteoarthritis Cartilage 2: 61–69

    Google Scholar 

  12. Noack W, Fischer M, Förster KK, Rovati LC, Setnikar I (1994) Glucosamine sulfate in osteoarthritis of the knee. Osteoarthritis Cartilage 2: 51–59

    PubMed  CAS  Google Scholar 

  13. Reichelt A, Forster KK, Fischer M, Rovati LC, Setnikar I (1994) Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee. A randomised, placebocontrolled, double-blind study. Arzneimittelforschung 44: 75–80

    PubMed  CAS  Google Scholar 

  14. Talent JM, Gracy RW (1996) Pilot study of oral polymeric N-acetyl-D-glucosamine as a potential treatment for patients with osteoarthritis. Clin Ther 18: 1184–1190

    PubMed  CAS  Google Scholar 

  15. Mazieres B, Loyou G, Menkes CJ, Valat JP, Dreiser RL, Chorlot J, Masounabe-Puyanne A (1992) La chondroitine sulfate dans le traitement de la gonarthrose et de la coxarthose. Resultats a 5 mois d’une etude aveugle versus placebo. Rev Rhum Mal Osteoartic S9: 466–472

    Google Scholar 

  16. L’Hirondel J (1992) Klinische doppelblind-studie mit oral verabreichtem chondroitinsulfat gegen placebo bei der tibiofemoralen gonarthrose. Litera Rheumatologica 14: 77–84

    Google Scholar 

  17. Conrozier T, Vignon E (1992) Die wirkung von chondroitinsulfat bei der behandlug der hüftgelenksarthrose. Litera Rheumatologica 14: 69–75

    Google Scholar 

  18. Morreale P, Manopulo R, Galati M, Boccanera L, Saponati G, Bocchi L (1996) Comparison of the antiinflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis. J Rheumatol 23: 1385–1391

    PubMed  CAS  Google Scholar 

  19. Bryant LR, des Rosier KF, Carpenter MT (1995) Hydroxychloroquine in the treatment of erosive osteoarthritis. J Rheumatol 22: 1527–1531

    PubMed  CAS  Google Scholar 

  20. Mannoni A, Altman RD, Muniz OE, Serni U, Dean DD (1993) The effects of methotrexate on normal and osteoarthritic lapine articular cartilage. J Rheumatol 20: 849–855

    PubMed  CAS  Google Scholar 

  21. Huskisson EC, Berry H, Gishen P, Jubb RW, Whitehead J (1995) Effects of antiinflammatory drugs on the progression of osteoarthritis of the knee. LINK Study Group. Longitudinal Investigation of Nonsteroidal Antiinflammatory Drugs in Knee Osteoarthritis. J Rheumatol 22: 1941–1946

    PubMed  CAS  Google Scholar 

  22. Distel M, Mueller C, Bluhmki E, Fries J (1996) Safety of meloxicam: a global analysis of clinical trials. Br J Rheumatol 35 Suppl 1: 68–77

    PubMed  CAS  Google Scholar 

  23. Bjarnason I, Macpherson A, Rotman H, Schupp J, Hayllar J (1997) A randomized, doubleblind, crossover comparative endoscopy study on the gastroduodenal tolerability of a highly specific cyclooxygenase-2 inhibitor, flosulide, and naproxen. Scand J Gastroenterol 32: 126–130

    PubMed  CAS  Google Scholar 

  24. Zhao SZ, Hatoum H, Hubbard R, Koepp J, Dedhiya S, Geis S, Bocanegra T, Ware J, Keller S (1997) Effect of celecoxib, a novel COX-2 inhibitor, on health-related quality of life of patients with osteoarthritis of the knee. Arthritis Rheum 40 (Suppl): S88–S88 (Abstract)

    Google Scholar 

  25. Dieppe PA, Sathapatayavongs B, Jones HE, Bacon PA, Ring EF (1980) Intra-articular steroids in osteoarthritis. Rheum Rehabil 19: 212–217

    CAS  Google Scholar 

  26. Friedman DM, Moore ME (1980) The efficacy of intraarticular steroids in osteoarthritis: a double- blind study. J Rheumatol 7: 850–856

    PubMed  CAS  Google Scholar 

  27. Valtonen EJ (1981) Clinical comparison of triamcinolonehexacetonide and betamethasone in the treatment of osteoarthrosis of the knee-joint. Scand J Rheumatol Suppl 41: 1–7

    PubMed  CAS  Google Scholar 

  28. Balch HW, Gibson JM, El-Ghobarey AF, Bain LS, Lynch MP (1977) Repeated corticosteroid injections into knee joints. Rheum Rehabil 16: 137–140

    CAS  Google Scholar 

  29. Pelletier JP, Mineau F, Raynauld JP, Woessner JF Jr, Gunja-Smith Z, Martel-Pelletier J (1994) Intraarticular injections with methylprednisolone acetate reduce osteoarthritic lesions in parallel with chondrocyte stromelysin synthesis in experimental osteoarthritis. Arthritis Rheum 37 (3): 414–423

    PubMed  CAS  Google Scholar 

  30. Namiki O, Toyoshima H, Morisaki N (1982) Therapeutic effect of intra-articular injection of high molecular weight hyaluronic acid on osteoarthritis of the knee. Int J Clin Pharm Ther Toxicol 20: 501–507

    CAS  Google Scholar 

  31. Bragantini A, Cassini M (1987) Controlled single-blind trial of intra-articulary injected hyaluronic acid in osteo-arthritis of the knee. Clin Trials Journal 24: 333–340

    Google Scholar 

  32. Dixon AS, Jacoby RK, Berry H, Hamilton EB (1988) Clinical trial of intra-articular injection of sodium hyaluronate in patients with osteoarthritis of the knee. Curr Med Res Opin 11: 205–213

    PubMed  CAS  Google Scholar 

  33. Dougados M, Nguyen M, Listrat V, Amor B (1993) High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage 1: 97–103

    PubMed  CAS  Google Scholar 

  34. Leardini G, Mattara L, Franceschini M, Perbellini A (1991) Intra-articular treatment of knee osteoarthritis. A comparative study between hyaluronic acid and 6-methyl prednisolone acetate. Clin Exp Rheumatol 9: 375–381

    PubMed  CAS  Google Scholar 

  35. Pietrogrande V, Melanotte PL, D’Agnolo B, Ulivi M, Benigni GA, Turchetto L, Pierfederici P, Perbellini A (1991) Hyaluronic acid versus methylprednisolone intra-articularly injected for the treatment of osteoarthritis of the knee. Curr Therap Res 50: 691–701

    Google Scholar 

  36. Jones AC, Pattrick M, Doherty S, Doherty M (1995) Intra-articular hyaluronic acid compared to intra-articular triamcinolone hexacetonide in inflammatory knee osteoarthritis. Osteoarthritis Cartilage 3: 269–273

    PubMed  CAS  Google Scholar 

  37. Lohmander LS, Dalen N, Englund G, Hamalainen M, Jensen EM, Karlsson K, Odensten M, Ryd L, Sernbo I, Suomalainen O et al. (1996) Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Hyaluronan Multicentre Trial Group. Ann Rheum Dis 55: 424–431

    PubMed  CAS  Google Scholar 

  38. Grecomoro G, Piccione F, Letizia G (1992) Therapeutic synergism between hyaluronic acid and dexamethasone in the intra-articular treatment of osteoarthritis of the knee: a preliminary open study. Curr Med Res Opin 13: 49–55

    PubMed  CAS  Google Scholar 

  39. Listrat V, Ayral X, Patarnello F, Bonvarlet JP, Simonnet J, Amor B, Dougados M (1997) Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis Cartilage 5: 153–160

    PubMed  CAS  Google Scholar 

  40. Scale D, Wobig M, Wolpert W (1994) Viscosupplementation of osteoarthritic knees with hylan: a treatment schedule study. Curr Therap Res 55: 220–232

    Google Scholar 

  41. Adams ME, Atkinson MH, Lussier AJ, Schulz JI, Siminovitch KA, Wade JP, Zummer M (1995) The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti- inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage 3: 213–225

    PubMed  CAS  Google Scholar 

  42. Lussier A, Cividino AA, McFarlane CA, Olszynski WP, Potashner WJ, De Medicis R (1996) Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. J Rheumatol 23: 1579–1585

    PubMed  CAS  Google Scholar 

  43. Vacha J, Pesakova V, Krajickova J, Adam M (1984) Effect of glycosaminoglycan polysulphate on the metabolism of cartilage ribonucleic acid. Arzneimittelforschung 34: 607–609

    PubMed  CAS  Google Scholar 

  44. Pavelka K Jr, Sedlackova M, Gatterova J, Becvar R, Pavelka K (1995) Glycosaminoglycan polysulfuric acid (GAGPS) in osteoarthritis of the knee. Osteoarthritis Cartilage 3: 15–23

    PubMed  Google Scholar 

  45. Grinnell F (1994) Fibroblasts, myofibroblasts, and wound contraction. J Cell Biol 124: 401–404

    PubMed  CAS  Google Scholar 

  46. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L (1994) Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331: 889–895

    PubMed  CAS  Google Scholar 

  47. Wakitani S, Goto T, Pineda SJ, Young RG, Mansour JM, Caplan AI, Goldberg VM (1994) Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am 76: 579–592

    PubMed  CAS  Google Scholar 

  48. Hommings GN, Bulstra SK, Bouwmeester PS, van der Linden AJ (1990) Perichondral grafting for cartilage lesions of the knee. J Bone Joint Surg [Br ] 72: 1003–1007

    Google Scholar 

  49. Kreder HJ, Moran M, Keeley FW, Salter RB (1994) Biologic resurfacing of a major joint defect with cryopreserved allogeneic periosteum under the influence of continuous passive motion in a rabbit model. Clin Orthop 288–296

    Google Scholar 

  50. Girdler NM (1993) Repair of articular defects with autologous mandibular condylar cartilage. J Bone Joint Surg [Br] 75: 710–714

    CAS  Google Scholar 

  51. Malinin TI, Mnaymneh W, Lo HK, Hinkle DK (1994) Cryopreservation of articular cartilage. Ultrastructural observations and long-term results of experimental distal femoral transplantation. Clin Orthop 18–32

    Google Scholar 

  52. Vacanti CA, Kim W, Schloo B, Upton J, Vacanti JP (1994) Joint resurfacing with cartilage grown in situ from cell-polymer structures. Am J Sports Med 22: 485–488

    PubMed  CAS  Google Scholar 

  53. Hendrickson DA, Nixon AJ, Grande DA, Todhunter RJ, Minor RM, Erb H, Lust G (1994) Chondrocyte-fibrin matrix transplants for resurfacing extensive articular cartilage defects. J Orthop Res

    Google Scholar 

  54. Nixon AJ, Sams AE, Lust G, Grande D, Mohammed HO (1993) Temporal matrix synthesis and histologic features of a chondrocyte-laden porous collagen cartilage analogue. Am J Vet Res 54: 349–356

    PubMed  CAS  Google Scholar 

  55. Freed LE, Marquis JC, Nohria A, Emmanual J, Mikos AG, Langer R (1993) Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res 27: 11–23

    PubMed  CAS  Google Scholar 

  56. Messner K (1994) Durability of artificial implants for repair of osteochondral defects of the medial femoral condyle in rabbits. Biomaterials 15: 657–664

    PubMed  CAS  Google Scholar 

  57. Messner K, Gillquist J (1993) Synthetic implants for the repair of osteochondral defects of the medial femoral condyle: a biomechanical and histological evaluation in the rabbit knee. Biomaterials 14: 513–521

    PubMed  CAS  Google Scholar 

  58. Burmester GR, Perka C, Sittinger M (1997) Tissue engineering: New ways to treat joint destruction in the next millenium. Proceedings of the EULAR Meeting S: 288: 71

    Google Scholar 

  59. Lafeber FPJG, van Roy HL, Van der Kraan PM, van den Berg WB, Bijlsma JW (1997) Transforming growth factor-beta predominantly stimulates phenotypically changed chondrocytes in osteoarthritic human cartilage. J Rheumatol 24: 536–542

    PubMed  CAS  Google Scholar 

  60. van den Berg WB (1995) Growth factors in experimental osteoarthritis: transforming growth factor beta pathogenic? J Rheum Suppl 43: 143–145

    CAS  Google Scholar 

  61. Rogachefsky RA, Dean DD, Howell DS, Altman RD (1993) Treatment of canine osteoarthritis with insulin-like growth factor-1 (IGF-1) and sodium pentosan polysulfate. Osteoarthritis Cartilage 1: 105–114

    PubMed  CAS  Google Scholar 

  62. Dinarello CA (1996) Biologic basis for interleukin-1 in disease. Blood 87 (6): 2095–2147

    PubMed  CAS  Google Scholar 

  63. Arend WP (1993) Interleukin-1 receptor antagonist. [Review] Adv Immunol 54: 167–227

    PubMed  CAS  Google Scholar 

  64. Jovanovic D, Pelletier JP, Alaaeddine N, Mineau F, Geng C, Ranger P, Martel-Pelletier J (1998) Effect of IL-13 on cytokines, cytokine receptors and inhibitors on human osteoarthritic synovium and synovial fibroblasts. Osteoarthritis Cartilage 6: 10–18

    Google Scholar 

  65. Bendrups A, Hilton A, Meager A, Hamilton JA (1993) Reduction of tumor necrosis factor alpha and interleukin-1 beta levels in human synovial tissue by interleukin-4 and glucocorticoid. Rheumatol Int 12: 217–220

    PubMed  CAS  Google Scholar 

  66. Katsikis PD, Chu CQ, Brennan FM, Maini RN, Feldmann M (1994) Immunoregulatory role of interleukin-10 in rheumatoid arthritis. J Exp Med 179: 1517–1527

    PubMed  CAS  Google Scholar 

  67. Hart PH, Ahern MJ, Smith MD, Finlay-Jones JJ (1995) Regulatory effects of IL-13 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Clin Exp Immunol 99: 331–337

    PubMed  CAS  Google Scholar 

  68. Defrance T, Carayon P, Billian G, Guillemot J-C, Minty A, Caput D, Ferrara P (1994) Interleukin-13 is a B cell stimulating factor. J Exp Med 179: 135–143

    PubMed  CAS  Google Scholar 

  69. de Waal Malefyt R, Figdor CG, Huijbens R, Mohan-Peterson S, Bennett B, Culpepper JA, Dang W, Zurawski G, de Vries JE (1993) Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J Immunol 151: 6370–6381

    PubMed  Google Scholar 

  70. Arend WP, Dayer JM (1995) Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum 38: 252–160

    Google Scholar 

  71. Evans CH, Robbins PD (1994) Gene therapy for arthritis. In: Wolff J A (eds) Gene Therapeutics: Methods and Applications of Direct Gene Transfer. Birkhauser, Boston, pp 320–343

    Google Scholar 

  72. Chernajovsky Y, Feldmann M, Maini RN (1995) Gene therapy of rheumatoid arthritis via cytokine regulation: future perspectives. Br Med Bull 51: 503–516

    PubMed  CAS  Google Scholar 

  73. Pelletier JP, Martel-Pelletier J, Howell DS (1997) Etiopathogenesis of osteoarthritis. In: Koopman W J (eds) Arthritis and Allied Conditions. A Textbook of Rheumatology. 13th edn Williams & Wilkins, Baltimore, pp 1969–1984.

    Google Scholar 

  74. Caron JP, Fernandes JC, Martel-Pelletier J, Tardif G, Mineau F, Geng C, Pelletier JP (1996) Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis: suppression of collagenase-1 expression. Arthritis Rheum 39: 1535–1544

    PubMed  CAS  Google Scholar 

  75. Müller-Ladner U, Roberts CR, Franklin BN, Gay RE, Robbins PD, Evans CH, Gay S (1997) Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective. J Immunol 158: 3492–3498

    PubMed  Google Scholar 

  76. Pelletier JP, Caron JP, Evans CH, Robbins PD, Georgescu HI, Jovanovic D, Fernandes JC, Martel-Pelletier J (1997) In vivo suppression of early experimental osteoarthritis by ILRa using gene therapy. Arthritis Rheum 40: 1012–1019

    PubMed  CAS  Google Scholar 

  77. Baragi VM, Renkiewicz RR, Jordan H, Bonadio J, Harman JW, Roessler BJ (1995) Transplantation of transduced chondrocytes protects articular cartilage from interleukin-1- induced extracellular matrix degradation. J Clin Invest 96: 2454–2460

    PubMed  CAS  Google Scholar 

  78. Tomita T, Hashimoto H, Tomita N, Morishita R, Lee SB, Hayashida K, Nakamura N, Yonenobu K, Kaneda Y, Ochi T (1997) In vivo direct gene transfer into articular cartilage by intraarticular injection mediated by HVJ (sendai virus) and liposomes. Arthritis Rheum 40 (5): 901–906

    PubMed  CAS  Google Scholar 

  79. Pelletier JP, Di Battista JA, Roughley PJ, McCollum R, Martel-Pelletier J (1993) Cytokines and inflammation in cartilage degradation. In: Moskowitz R W (eds) Osteoarthritis, Edition of Rheumatic Disease Clinics of North America. W.B. Saunders Company, Philadelphia, pp 545–568.

    Google Scholar 

  80. Martel-Pelletier J, Mineau F, Tardif G, Fernandes JC, Ranger P, Loose L, Pelletier JP (1996) Tenidap reduces the level of interleukin-1 receptors and collagenase expression in human arthritic synovial fibroblasts. J Rheumatol 23: 24–31

    PubMed  CAS  Google Scholar 

  81. Fernandes JC, Martel-Pelletier J, Otterness IG, Lopez-Anaya A, Mineau F, Tardif G, Pelletier JP (1995) Effects of tenidap on canine experimental osteoarthritis: I. Morphologic and metalloprotease analysis. Arthritis Rheum 38: 1290–1303

    PubMed  CAS  Google Scholar 

  82. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys RJ, Landvatter SW et al. (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372: 739

    PubMed  CAS  Google Scholar 

  83. Ridley SH, Sarsfield SJ, Lee JC, Bigg HF, Cawston TE, Taylor DJ, DeWitt DL, Saklatvala J (1997) Actions of IL-1 are selectively controlled by P38 mitogen-activated protein kinease regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels. J Immunol 158: 3165–3173

    PubMed  CAS  Google Scholar 

  84. Fujiwara T, Grimm EA (1992) Specific inhibition of interleukin-1 beta gene expression by an antisense oligonucleotide: obligatory role of interleukin-1 in the generation of lymphokine-activated killer cells. Cancer Res 52 (18): 14954–4959

    Google Scholar 

  85. Manson J, Brown T, Duff G (1990) Modulation of interleukin-1 beta gene expression using antisense phosphorothioate oligonucleotides. Lymphokine Res 9: 35–42

    PubMed  CAS  Google Scholar 

  86. Cerretti DP, Kozlosky CJ, Mosley B, Nelson N, Van Ness K, Greenstreet TA, March CJ, Kronheim SR, Druck T, Cannizzaro LA (1992) Molecular cloning of the interleukin-1 beta converting enzyme. Science 256: 97–100

    PubMed  CAS  Google Scholar 

  87. Stosic-Grujicic S, Basara N, Milenkovic P, Dinarello CA (1995) Modulation of acute myeloblasts leukemia (AML) cell proliferation and blast colony formation by antisense oligomer for IL-1 beta converting enzyme (ICE) and IL-1 receptor antagonist (IL-1ra). J Chemother 7: 67–70

    PubMed  CAS  Google Scholar 

  88. Ku G, Faust T, Lauffer LL, Livingston DJ, Harding MW (1996) Interleukin-1ß converting enzyme inhibition blocks progression of the type II collagen-induced arthritis in mice. Cytokine 8: 377–386

    PubMed  CAS  Google Scholar 

  89. Burger D, Chicheportiche R, Giri JG, Dayer JM (1995) The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor. J Clin Invest 96: 38–41

    PubMed  CAS  Google Scholar 

  90. Joosten LA, Helsen MM, van de Loo FA, van den Berg WB (1996) Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti- IL-1 alpha/beta, and IL-1Ra. Arthritis Rheum 39: 797–809

    PubMed  CAS  Google Scholar 

  91. Westacott CI, Atkins RM, Dieppe PA, Elson CJ (1994) Tumour necrosis factor-alpha receptor expression on chondrocytes isolated from human articular cartilage. J Rheumatol 21: 1710–1715

    PubMed  CAS  Google Scholar 

  92. Martel-Pelletier J, Mineau F, Jolicoeur FC, Pelletier JP (1995) Modulation of TNFsR55 and TNFsR75 by cytokines and growth factors in human synovial fibroblasts. J Rheumatol 22: 115–119

    Google Scholar 

  93. Williams RO, Ghrayeb J, Feldmann M, Maini RN (1995) Successful therapy of collageninduced arthritis with TNF receptor-IgG fusion protein and combination with anti-CD4. Immunology 84: 433–439

    PubMed  CAS  Google Scholar 

  94. Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, Leeb B, Breedveld FC, Macfarlane JD, Bijl H (1994) Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 344: 1105–1110

    PubMed  CAS  Google Scholar 

  95. Evans CH, Stefanovic-Racic M, Lancaster J (1995) Nitric oxide and its role in orthopaedic disease. Clin Orthop 312: 275–294

    PubMed  Google Scholar 

  96. Mclnnes IB, Leung BP, Field M, Wei XQ, Huang FP, Sturrock RD, Kinninmonth A, Weidner J, Mumford R, Liew FY (1996) Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med 184: 1519–1524

    Google Scholar 

  97. Nathan C (1997) Inducible nitric oxide synthase: what difference does it make? J Clin Invest 100: 2417–2423

    PubMed  CAS  Google Scholar 

  98. Pelletier JP, Mineau F, Ranger P, Tardif G, Martel-Pelletier J (1996) The increased synthesis of inducible nitric oxide inhibits IL-1Ra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation. Osteoarthritis Cartilage 4: 77–84

    PubMed  CAS  Google Scholar 

  99. Jarvinen TAH, Moilanen T, Järvinen TLN, Moilanen E (1995) Nitric oxide mediates in terleukin-1 induced inhibition of glycosaminoglycan synthesis in rat articular cartilage. Mediators of Inflammation 4: 107–111

    PubMed  CAS  Google Scholar 

  100. Murrell GAC, Jang D, Williams RJ (1995) Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun 206: 15–21

    PubMed  CAS  Google Scholar 

  101. Farrell AJ, Blake DR, Palmer RM, Moncada S (1992) Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 51: 1219–1222

    PubMed  CAS  Google Scholar 

  102. Grabowski PS, Wright PK, Van’t Hof RJ, Helfrich MH, Ohshima H, Ralston SH (1997) Immunolocalization of inducible nitric oxide synthase in synovium and cartilage in rheumatoid arthritis and osteoarthritis. Br J Rheumatol 36: 651–655

    PubMed  CAS  Google Scholar 

  103. Amin AR, Di Cesare PE, Vyas P, Attur MG, Tzeng E, Billiar TR, Stuchin S, Abramson SB (1995) The expression and regulation of nitric oxide synthase in human osteoarthritis- affected chondrocytes: evidence for an inducible “neuronal-like” nitric oxide synthase. J Exp Med 182: 2097–2102

    PubMed  CAS  Google Scholar 

  104. Stefanovic-Racic M, Stadler J, Evans CH (1993) Nitric oxide and arthritis. Arthritis Rheum 36: 1036–1044

    PubMed  CAS  Google Scholar 

  105. Connor JR, Manning PT, Settle SL, Moore WM, Jerome GM, Webber RK, Tjoeng FS, Currie MG (1995) Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. Eur J Pharmacol 273: 15–24

    PubMed  CAS  Google Scholar 

  106. Stefanovic-Racic M, Meyers K, Meschter C, Coffey JW, Hoffman RA, Evans CH (1994) N- monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis Rheum 37: 1062–1069

    PubMed  CAS  Google Scholar 

  107. Stefanovic-Racic M, Meyers K, Meschter C, Coffey JW, Hoffman RA, Evans CH (1995) Comparison of the nitric oxide synthase inhibitors methylarginine and aminoguanidine as prophylactic and therapeutic agents in rat adjuvant arthritis. J Rheumatol 22: 1922–1928

    PubMed  CAS  Google Scholar 

  108. McCartney-Francis N, Allen JB, Mizel DE, Albina JE, Xie Q, Nathan DF, Wahl SM (1993) Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 178: 749–754

    PubMed  CAS  Google Scholar 

  109. Pelletier JP, Jovanovic D, Fernandes JC, Manning PT, Connor JR, Currie MG, Di Battista JA, Martel-Pelletier J (1998) Selective inhibition of inducible nitric oxide synthase reduces in vivo the progression of experimental osteoarthritis. Arthritis Rheum (in press)

    Google Scholar 

  110. Dean DD (1991) Proteinase-mediated cartilage degradation in osteoarthritis. Semin Arthritis Rheum 20: 2–11

    PubMed  CAS  Google Scholar 

  111. Martel-Pelletier J, Pelletier JP (1996) Wanted — the collagenase responsible for the destruction of the collagen network in human cartilage. Br J Rheumatol 35: 818–820

    PubMed  CAS  Google Scholar 

  112. Vincenti MP, Clark IM, Brinckerhoff CE (1994) Using inhibitors of metalloproteinases to treat arthritis. Easier said than done? [Review]. Arthritis Rheum 37: 1115–1126

    PubMed  CAS  Google Scholar 

  113. Yu LP Jr, Smith GN Jr, Brandt KD, Myers SL, O’Connor BL, Brandt DA (1992) Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline. Arthritis Rheum 35: 1150–1159

    PubMed  Google Scholar 

  114. MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L et al. (1997) Discovery of CGS 27023 A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits. J Med Chem 40: 2525–2532

    PubMed  CAS  Google Scholar 

  115. Lewis EJ, Bishop J, Bottomley KM, Bradshaw D, Brewster M, Broadhurst MJ, Brown PA, Budd JM, Elliott L, Greenham AK et al. (1997) Ro 32-3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivo. Br J Pharmacol 121: 540–546

    PubMed  CAS  Google Scholar 

  116. DiMartino M, Wolff C, High W, Stroup G, Hoffman S, Laydon J, Lee JC, Bertolini D, Galloway WA, Crimmin MJ et al. (1997) Anti-arthritic activity of hydroxamic acid-based pseudopeptide inhibitors of matrix metalloproteinases and TNF alpha processing. Inflamm Res 46: 211–215

    PubMed  CAS  Google Scholar 

  117. Hirayama R, Yamamoto M, Tsukida T, Matsuo K, Obata Y, Sakamoto F, Ikeda S (1997) Synthesis and biological evaluation of orally active matrix metalloproteinase inhibitors. Bioorg Med Chem 5: 765–778

    PubMed  CAS  Google Scholar 

  118. Vincenti MP, White LA, Schroen DJ, Benbow U, Brinckerhoff CE (1996) Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): mechanisms that control enzyme activity, transcription, and mRNA stability. Crit Rev Eukaryot Gene Exp 6: 391–411

    CAS  Google Scholar 

Download references

Authors
  1. J. P. Pelletier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Haraoui
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. C. Fernandes
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Pelletier, J.P., Haraoui, B., Fernandes, J.C. (1999). New and Future Therapies for Osteoarthritis. In: Osteoarthritis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60026-5_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60026-5_20

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-65127-7

  • Online ISBN: 978-3-642-60026-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation